FDA Authorizes Software that Can Help Identify Prostate Cancer

FDA authorizes software to assist pathologists detect areas that are suspicious for cancer as an adjunct to the standard of care review of ...

FDA Authorizes AI-Based Software to Assist in Prostate Cancer ...

“The authorization of this AI-based software can help increase the number of identified prostate biopsy samples with cancerous tissue, which can ...

FDA authorizes software that can help identify prostate cancer

The U.S. Food and Drug Administration (FDA) approved the use of a software product to assist pathologists in the detection of prostate ...

FDA authorizes AI-based software for prostate cancer detection

“The authorization of this AI-based software can help increase the number of identified prostate biopsy samples with cancerous tissue, which can ...

FDA Approves First AI Device to Assist With Prostate Cancer Detection

The FDA authorized the marketing of Paige Prostate, the first ratification-intelligence-based software designed to identify areas with high ...

FDA Authorizes Paige Prostate's AI Software to Help ... - GoodRx

Paige Prostate is the first AI artificial intelligence (AI) software designed to help detect prostate cancer. Created by Paige AI, ...

FDA authorizes software to identify prostate cancer

The U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues ...

AI-Driven Software Based Off NIH Algorithm Receives FDA ... - CBIIT

AI-Driven Software Based Off NIH Algorithm Receives FDA Clearance in Detection and Diagnosis of Prostate Cancer · The physician will order a non- ...

Artificial intelligence–assisted cancer diagnosis improves the ...

[14] which is designed to assist the pathologist in the diagnosis of prostate cancer. ... The software was comprised of Paige Prostate Detect (FDA ...

FDA Authorizes Prostate AI Software - Axis Imaging News

The U.S. FDA has authorized marketing of software to assist pathologists in the detection of areas that are suspicious for cancer as an adjunct ...

Quibim receives FDA 510(k) Clearance for QP-Prostate, a new AI ...

Quibim receives FDA 510(k) Clearance for QP-Prostate, a new AI solution for prostate MRI analysis · Groundbreaking AI tool brings analytical processes into one ...

FDA Authorizes AI Software Designed to Help Spot Prostate Cancer

The FDA said Paige Prostate is the first AI-based software program it has authorized that is designed to identify areas of interest in prostate biopsy.

FDA authorizes first AI-based software used to spot prostate cancer

“The authorization of this AI-based software can help increase the number of identified prostate biopsy samples with cancerous tissue, which can ...

Introducing FDA-Approved Paige Prostate

Software to Enhance Confidence in Prostate Cancer Diagnosis · FDA-approved Paige Prostate leverages clinical-grade AI to transform prostate biopsy diagnosis by ...

FDA authorises the first AI-based software to detect prostate cancer

Paige Prostate will allow pathologists to work more confidently and focus more on key elements of the diagnostic process.

Artificial intelligence in prostate cancer: Definitions, current research ...

A recent study has revealed that a deep learning integrated nomogram, “CIaD,” was successfully able to accurately risk stratify patients and aid in proper ...

Novel AI-Based Web Tool Shows Promise for Prostate Cancer ...

“This work will provide a more accurate and timelier diagnosis and grading than the manual existing process in prostate cancer diagnosis,” said ...

UK study of AI-based software for prostate cancer detection expands

The FDA authorized the marketing of Paige Prostate in the US in September 2021. Hospitals now included in the 2-year study are North Bristol ...

PROSTATE CANCER Artificial Intelligence in Radical Prostatectomy

Similarly, AI has shown promise in interpretation of prostate biopsy histopathology. Paige Prostate, a commercial AI software for automated ...

Artificial intelligence in diagnostic pathology - PMC - PubMed Central

2021: FDA authorizes the first AI-based software to detect prostate cancer (Paige Prostate) [21]. Role of AI in pathology: a brief overview.